Increased Dose in Spine Stereotactic Radiosurgery for Metastatic Disease: Are We Underestimating the Risks?

<i>Background and Objectives</i>: The recently published Spine Stereotactic Radiosurgery (SSRS) ESTRO guidelines advise against treating spinal metastatic disease with a single dose equal to or smaller than 18 Gy, prioritizing local control over the potential for complications. This study aims to as...

詳細記述

書誌詳細

主要な著者:	Gil Kimchi, Maya Nulman, Saeda Haj, Idan Bar-Orian, Ory Haisraely, Ran Harel
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2024-09-01
シリーズ:	Medicina
主題:	spine tumors spine radiosurgery stereotactic body radiotherapy guidelines radiation dose
オンライン･アクセス:	https://www.mdpi.com/1648-9144/60/9/1514
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!